Articles & Video
REPORT: Adoption of AI and Digital Solutions in the MedTech Industry
This exclusive report looks at how AI and digital solutions have been adopted in the MedTech industry, and what the future looks like.
5 ways that venture capital investors can drive diversity in biotech
What responsibilities do investors have to increase diversity in the biotech sector? We look at key strategies discussed at BioPharm America Digital.
Clinical Evaluations for Medical Devices and IVDs - MedTech eBook Series
Discover how the EU MDR will affect clinical evaluations for medical devices and IVDs in this MedTech Summit eBook.
Report: Partnering And Deal-Making in Pharma through the Pandemic
This Informa report explores how partnering and deal-making in the pharma industry has been impacted by COVID-19.
Biopharma Partnering and Financing Trends, H1 2020
With the help of Biomedtracker, analysts at Pharma Intelligence have taken a deep dive into the worldwide biopharma industry partnership and financial dealmaking during the first halves of 2019 and 2020. What they found is astounding and inside the new white paper.
How Emerging Biomarkers in Non-Small Cell Lung Cancer are Driving New & Innovative Targeted Treatments
Biotech Startups: How to Succeed in a COVID-19 World
Taking a biotech company from concept, through clinical trials, and ultimately to market requires a perfect storm of good science, a sound investment, and the right management. This ebook is here to guide startups through this journey.
REPORT: The Future of Healthcare Post COVID-19
In our latest report learn how healthcare organizations are adapting to succeed post COVID-19, from innovation to product development.
Interview: Importance of diversity and partnering in global life sciences
ATLATL Innovation Cluster (IC) in the heart of Zhangjiang Pharma Valley. Its Founder and CEO, Dr. P.C. Zhu, designed it to be a launchpad for high-potential life sciences in China. In this interview with EBD Group he discusses the opportunities ATLATL provides and the importance of partnering in the life science industry.
Video Interview - Johnson & Johnson’s approach to external innovation
William N. Hait, MD, PhD, Global Head at Johnson & Johnson External Innovation gives an exclusive interview to Lucie Ellis, Executive Editor of In Vivo, Pharma Intelligence, ahead of ChinaBio® Partnering Forum Digital.
Interview – J&J’s multi-pronged approach to life science innovation, partnerships, and advanced technologies
Dr. Dan Wang, Head, Johnson & Johnson Innovation, Asia Pacific, and Dr. Sharon Chan, Head of JLABS @ Shanghai discuss its support of startups, interests in diverse disease areas, the importance of collaborations and much more in this exclusive interview with EBD Group.
REPORT: State of China Life Science - 2020 H1
Download this new exclusive ChinaBio® report with in-depth analysis of investment and partnering activity in China for 2020 H1 to discover the factors driving China life science investment. Learn how VC, IPO, and Partnering have rebounded despite COVID-19, but how M&A continues to slump.
China's Challenges and Opportunities in the Wake of COVID-19
Discover how pharma companies in China are collaborating like never before to keep the supply chain from breaking, as well as asking the government to help address a flurry of issues laid bare by the public health crisis.
Interview- Roche’s approach to drug discovery, innovation and meeting patients' needs
James Sabry, Global Head of Roche Pharma Partnering, discusses Roche’s approach to discovering scientific breakthroughs, accelerating innovative research, collaborating with stakeholders, and meeting unmet medical needs in China and around the world.
The biggest breakthroughs in life sciences the last 10 years
CRISPR, CAR-T, immunotherapies, genome sequencing, AI - what is the biggest breakthrough in the life sciences in the last 10 years?
Diversity in the life sciences workplace: Implementing a leading corporate culture for innovation - WHITEPAPER
This paper looks at how to foster racial, gender, geographical, neuro and cognitive diversity in the life sciences to achieve an inclusive culture built for innovation.
REPORT: Diversity, Inclusion and Sustainability in the Global Life Sciences Industry 2020
Diversity and Inclusion in Life Sciences 2020: Research analysis of how life sciences professionals around the world view representation of women and minorities in the industry, plus the importance of sustainability.
Looking to 2030 Report: The Future of the Global Life Sciences and Pharma Industry
This exclusive report looks at predictions for how the global life sciences and pharma industry will change over the coming decade.
COVID-19 Report: The Response to and Impacts on the Global Life Sciences Industry
COVID-19 Report: How is the life sciences industry developing a vaccine, treatment and testing for COVID-19 and what impact is it having on supply chain?
Containing Coronavirus Through Innovation and Investment: An Xconomy Special Report
This report contains ideas, innovation, and experience from some of the major players at the forefront of efforts in combatting COVID-19. The exclusive articles were captured from the BIO-Europe Spring® event and are accompanied by some of the most pertinent stories from B2B publications Xconomy and Bioprocess Insider.